{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:31:55Z","timestamp":1773660715303,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00277-020-03909-7","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T07:03:01Z","timestamp":1580454181000},"page":"487-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["t(11;16)(q23;p13)\/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1815-7666","authenticated-orcid":false,"given":"Wei","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Cloe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanam","family":"Loghavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagop M.","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"issue":"2","key":"3909_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/leu.2017.213","volume":"32","author":"C Meyer","year":"2018","unstructured":"Meyer C, Burmeister T, Groger D, Tsaur G, Fechina L, Renneville A, Sutton R, Venn NC, Emerenciano M, Pombo-de-Oliveira MS, Barbieri Blunck C, Almeida Lopes B, Zuna J, Trka J, Ballerini P, Lapillonne H, De Braekeleer M, Cazzaniga G, Corral Abascal L, van der Velden VHJ, Delabesse E, Park TS, Oh SH, Silva MLM, Lund-Aho T, Juvonen V, Moore AS, Heidenreich O, Vormoor J, Zerkalenkova E, Olshanskaya Y, Bueno C, Menendez P, Teigler-Schlegel A, Zur Stadt U, Lentes J, Gohring G, Kustanovich A, Aleinikova O, Schafer BW, Kubetzko S, Madsen HO, Gruhn B, Duarte X, Gameiro P, Lippert E, Bidet A, Cayuela JM, Clappier E, Alonso CN, Zwaan CM, van den Heuvel-Eibrink MM, Izraeli S, Trakhtenbrot L, Archer P, Hancock J, Moricke A, Alten J, Schrappe M, Stanulla M, Strehl S, Attarbaschi A, Dworzak M, Haas OA, Panzer-Grumayer R, Sedek L, Szczepanski T, Caye A, Suarez L, Cave H, Marschalek R (2018) The MLL recombinome of acute leukemias in 2017. Leukemia 32(2):273\u2013284. https:\/\/doi.org\/10.1038\/leu.2017.213","journal-title":"Leukemia"},{"issue":"8","key":"3909_CR2","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1111\/j.1742-4658.2010.07609.x","volume":"277","author":"MS Cosgrove","year":"2010","unstructured":"Cosgrove MS, Patel A (2010) Mixed lineage leukemia: a structure-function perspective of the MLL1 protein. FEBS J 277(8):1832\u20131842. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07609.x","journal-title":"FEBS J"},{"issue":"2","key":"3909_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/bip.22126","volume":"99","author":"P Zhang","year":"2013","unstructured":"Zhang P, Bergamin E, Couture JF (2013) The many facets of MLL1 regulation. Biopolymers 99(2):136\u2013145. https:\/\/doi.org\/10.1002\/bip.22126","journal-title":"Biopolymers"},{"issue":"24","key":"3909_CR4","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.1073\/pnas.0503072102","volume":"102","author":"MG Guenther","year":"2005","unstructured":"Guenther MG, Jenner RG, Chevalier B, Nakamura T, Croce CM, Canaani E, Young RA (2005) Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A 102(24):8603\u20138608. https:\/\/doi.org\/10.1073\/pnas.0503072102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3909_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fped.2017.00004","volume":"5","author":"AC Winters","year":"2017","unstructured":"Winters AC, Bernt KM (2017) MLL-rearranged leukemias-an update on science and clinical approaches. Front Pediatr 5:4. https:\/\/doi.org\/10.3389\/fped.2017.00004","journal-title":"Front Pediatr"},{"issue":"13","key":"3909_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.4161\/cbt.8.13.8924","volume":"8","author":"H Liu","year":"2009","unstructured":"Liu H, Cheng EH, Hsieh JJ (2009) MLL fusions: pathways to leukemia. Cancer Biol Ther 8(13):1204\u20131211. https:\/\/doi.org\/10.4161\/cbt.8.13.8924","journal-title":"Cancer Biol Ther"},{"key":"3909_CR7","unstructured":"Swerdlow SH,\u00a0Campo E, Harris NL et al (eds)\u00a0(2017) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th ed. IARC, Lyon"},{"issue":"11","key":"3909_CR8","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1182\/blood.V89.11.3945","volume":"89","author":"T Taki","year":"1997","unstructured":"Taki T, Sako M, Tsuchida M, Hayashi Y (1997) The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89(11):3945\u20133950","journal-title":"Blood"},{"issue":"2","key":"3909_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cancergencyto.2006.02.013","volume":"168","author":"C Stasik","year":"2006","unstructured":"Stasik C, Ganguly S, Cunningham MT, Hagemeister S, Persons DL (2006) Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia. Cancer Genet Cytogenet 168(2):146\u2013149. https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.02.013","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"3909_CR10","first-page":"535","volume":"90","author":"JD Rowley","year":"1997","unstructured":"Rowley JD, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Borrow J, Zeleznik-Le N (1997) All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 90(2):535\u2013541","journal-title":"Blood"},{"issue":"4","key":"3909_CR11","first-page":"1139","volume":"60","author":"Y Hayashi","year":"2000","unstructured":"Hayashi Y, Honma Y, Niitsu N, Taki T, Bessho F, Sako M, Mori T, Yanagisawa M, Tsuji K, Nakahata T (2000) SN-1, a novel leukemic cell line with t(11;16)(q23;p13): myeloid characteristics and resistance to retinoids and vitamin D3. Cancer Res 60(4):1139\u20131145","journal-title":"Cancer Res"},{"issue":"3","key":"3909_CR12","first-page":"285","volume":"33","author":"AB Glassman","year":"2003","unstructured":"Glassman AB, Hayes KJ (2003) Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome. Ann Clin Lab Sci 33(3):285\u2013288","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"3909_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1309\/RX27-R8GJ-QM33-0C22","volume":"122","author":"MC Cox","year":"2004","unstructured":"Cox MC, Panetta P, Lo-Coco F, Del Poeta G, Venditti A, Maurillo L, Del Principe MI, Mauriello A, Anemona L, Bruno A, Mazzone C, Palombo P, Amadori S (2004) Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. Am J Clin Pathol 122(2):298\u2013306. https:\/\/doi.org\/10.1309\/RX27-R8GJ-QM33-0C22","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"3909_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1200\/JCO.1993.11.2.209","volume":"11","author":"NJ Winick","year":"1993","unstructured":"Winick NJ, McKenna RW, Shuster JJ, Schneider NR, Borowitz MJ, Bowman WP, Jacaruso D, Kamen BA, Buchanan GR (1993) Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 11(2):209\u2013217. https:\/\/doi.org\/10.1200\/JCO.1993.11.2.209","journal-title":"J Clin Oncol"},{"issue":"3","key":"3909_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/(SICI)1098-2264(200003)27:3<264::AID-GCC6>3.0.CO;2-#","volume":"27","author":"K Sugita","year":"2000","unstructured":"Sugita K, Taki T, Hayashi Y, Shimaoka H, Kumazaki H, Inoue H, Konno Y, Taniwaki M, Kurosawa H, Eguchi M (2000) MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia. Genes Chromosom Cancer 27(3):264\u2013269","journal-title":"Genes Chromosom Cancer"},{"issue":"12","key":"3909_CR16","first-page":"1990","volume":"9","author":"CH Pui","year":"1995","unstructured":"Pui CH, Relling MV, Rivera GK, Hancock ML, Raimondi SC, Heslop HE, Santana VM, Ribeiro RC, Sandlund JT, Mahmoud HH et al (1995) Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia 9(12):1990\u20131996","journal-title":"Leukemia"},{"issue":"9","key":"3909_CR17","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1182\/blood.V86.9.3613.bloodjournal8693613","volume":"86","author":"D Roulston","year":"1995","unstructured":"Roulston D, Anastasi J, Rudinsky R, Nucifora G, Zeleznik-Le N, Rowley JD, McGavran L, Tsuchida M, Hayashi Y (1995) Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases. Blood 86(9):3613\u20133614","journal-title":"Blood"},{"issue":"4","key":"3909_CR18","first-page":"403","volume":"89","author":"C Sambani","year":"2004","unstructured":"Sambani C, La Starza R, Roumier C, Crescenzi B, Stavropoulou C, Katsarou O, Karafoulidou A, Dhalle JH, Lai JL, Preudhomme C, Martelli MF, Mecucci C (2004) Partial duplication of the MLL oncogene in patients with aggressive acute myeloid leukemia. Haematologica 89(4):403\u2013407","journal-title":"Haematologica"},{"issue":"3","key":"3909_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1046\/j.1365-2141.1996.00399.x","volume":"92","author":"Y Zhang","year":"1996","unstructured":"Zhang Y, Poetsch M, Weber-Matthiesen K, Rohde K, Winkemann M, Haferlach T, Gassmann W, Ludwig WD, Grote W, Loffler H, Schlegelberger B (1996) Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies. Br J Haematol 92(3):673\u2013680","journal-title":"Br J Haematol"},{"issue":"2","key":"3909_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cancergencyto.2006.02.006","volume":"168","author":"W Shali","year":"2006","unstructured":"Shali W, Helias C, Fohrer C, Struski S, Gervais C, Falkenrodt A, Leymarie V, Lioure B, Raby P, Herbrecht R, Lessard M (2006) Cytogenetic studies of a series of 43 consecutive secondary myelodysplastic syndromes\/acute myeloid leukemias: conventional cytogenetics, FISH, and multiplex FISH. Cancer Genet Cytogenet 168(2):133\u2013145. https:\/\/doi.org\/10.1016\/j.cancergencyto.2006.02.006","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"3909_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/sj.leu.2400576","volume":"11","author":"JH Laver","year":"1997","unstructured":"Laver JH, Yusuf U, Cantu ES, Barredo JC, Holt LB, Abboud MR (1997) Transient therapy-related myelodysplastic syndrome associated with monosomy 7 and 11q23 translocation. Leukemia 11(3):448\u2013450","journal-title":"Leukemia"},{"issue":"1","key":"3909_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/(SICI)1098-2264(199709)20:1<60::AID-GCC9>3.0.CO;2-7","volume":"20","author":"N Satake","year":"1997","unstructured":"Satake N, Ishida Y, Otoh Y, Hinohara S, Kobayashi H, Sakashita A, Maseki N, Kaneko Y (1997) Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation. Genes Chromosom Cancer 20(1):60\u201363","journal-title":"Genes Chromosom Cancer"},{"issue":"12","key":"3909_CR23","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1182\/blood.V81.12.3197.3197","volume":"81","author":"SP Hunger","year":"1993","unstructured":"Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML (1993) HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 81(12):3197\u20133203","journal-title":"Blood"},{"issue":"1","key":"3909_CR24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3324\/haematol.2014.110775","volume":"100","author":"M. A. Sanders","year":"2014","unstructured":"Sanders MA, Kavelaars FG, Zeilemaker A, Al Hinai AS, Abbas S, Beverloo HB, van Lom K, Valk PJ (2015) RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia. Haematologica 100. https:\/\/doi.org\/10.3324\/haematol.2014.110775","journal-title":"Haematologica"},{"issue":"8","key":"3909_CR25","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1182\/blood-2007-10-119230","volume":"111","author":"S Lugthart","year":"2008","unstructured":"Lugthart S, van Drunen E, van Norden Y, van Hoven A, Erpelinck CA, Valk PJ, Beverloo HB, Lowenberg B, Delwel R (2008) High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood 111(8):4329\u20134337. https:\/\/doi.org\/10.1182\/blood-2007-10-119230","journal-title":"Blood"},{"issue":"16","key":"3909_CR26","doi-asserted-by":"publisher","first-page":"8732","DOI":"10.1073\/pnas.94.16.8732","volume":"94","author":"OM Sobulo","year":"1997","unstructured":"Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ (1997) MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci U S A 94(16):8732\u20138737","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3909_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1139\/o01-076","volume":"79","author":"KJ McManus","year":"2001","unstructured":"McManus KJ, Hendzel MJ (2001) CBP, a transcriptional coactivator and acetyltransferase. Biochem Cell Biol 79(3):253\u2013266","journal-title":"Biochem Cell Biol"},{"issue":"9","key":"3909_CR28","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/cncr.21401","volume":"104","author":"DB Shankar","year":"2005","unstructured":"Shankar DB, Cheng JC, Sakamoto KM (2005) Role of cyclic AMP response element binding protein in human leukemias. Cancer 104(9):1819\u20131824. https:\/\/doi.org\/10.1002\/cncr.21401","journal-title":"Cancer"},{"issue":"7","key":"3909_CR29","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41379-018-0014-x","volume":"31","author":"H Kurt","year":"2018","unstructured":"Kurt H, Zheng L, Kantarjian HM, Tang G, Ravandi-Kashani F, Garcia-Manero G, Gong Z, Amin HM, Konoplev SN, Routbort MJ, Han X, Wang W, Medeiros LJ, Hu S (2018) Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome. Mod Pathol 31(7):1141\u20131154. https:\/\/doi.org\/10.1038\/s41379-018-0014-x","journal-title":"Mod Pathol"},{"issue":"3","key":"3909_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.leukres.2014.12.006","volume":"39","author":"CY Ok","year":"2015","unstructured":"Ok CY, Patel KP, Garcia-Manero G, Routbort MJ, Fu B, Tang G, Goswami M, Singh R, Kanagal-Shamanna R, Pierce SA, Young KH, Kantarjian HM, Medeiros LJ, Luthra R, Wang SA (2015) Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Leuk Res 39(3):348\u2013354. https:\/\/doi.org\/10.1016\/j.leukres.2014.12.006","journal-title":"Leuk Res"},{"issue":"10","key":"3909_CR31","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/modpathol.2012.88","volume":"25","author":"M Warren","year":"2012","unstructured":"Warren M, Luthra R, Yin CC, Ravandi F, Cortes JE, Kantarjian HM, Medeiros LJ, Zuo Z (2012) Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients. Mod Pathol 25(10):1405\u20131412. https:\/\/doi.org\/10.1038\/modpathol.2012.88","journal-title":"Mod Pathol"},{"issue":"2","key":"3909_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jmoldx.2018.10.005","volume":"21","author":"G Tang","year":"2019","unstructured":"Tang G, Hu S, Wang SA, Xie W, Lin P, Xu J, Toruner G, Zhao M, Gu J, Doty M, Li S, Medeiros LJ, Tang Z (2019) t(3;8)(q26.2;q24) often leads to MECOM\/MYC rearrangement and is commonly associated with therapy-related myeloid neoplasms and\/or disease progression. J Mol Diagn 21(2):343\u2013351. https:\/\/doi.org\/10.1016\/j.jmoldx.2018.10.005","journal-title":"J Mol Diagn"},{"issue":"9","key":"3909_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrc.2017.60","volume":"17","author":"ME McNerney","year":"2017","unstructured":"McNerney ME, Godley LA, Le Beau MM (2017) Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer 17(9):513\u2013527. https:\/\/doi.org\/10.1038\/nrc.2017.60","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"3909_CR34","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/sj.onc.1209948","volume":"26","author":"S Scharf","year":"2007","unstructured":"Scharf S, Zech J, Bursen A, Schraets D, Oliver PL, Kliem S, Pfitzner E, Gillert E, Dingermann T, Marschalek R (2007) Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL gene. Oncogene 26(10):1361\u20131371. https:\/\/doi.org\/10.1038\/sj.onc.1209948","journal-title":"Oncogene"},{"issue":"Suppl 2","key":"3909_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.0960-135X.2004.01366.x","volume":"34","author":"G Mitterbauer-Hohendanner","year":"2004","unstructured":"Mitterbauer-Hohendanner G, Mannhalter C (2004) The biological and clinical significance of MLL abnormalities in haematological malignancies. Eur J Clin Investig 34(Suppl 2):12\u201324. https:\/\/doi.org\/10.1111\/j.0960-135X.2004.01366.x","journal-title":"Eur J Clin Investig"},{"issue":"2","key":"3909_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/sj.emboj.7600521","volume":"24","author":"J Wang","year":"2005","unstructured":"Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, Korsmeyer SJ (2005) Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBO J 24(2):368\u2013381. https:\/\/doi.org\/10.1038\/sj.emboj.7600521","journal-title":"EMBO J"},{"issue":"5","key":"3909_CR37","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00277-019-03637-7","volume":"98","author":"W Xie","year":"2019","unstructured":"Xie W, Hu S, Xu J, Chen Z, Medeiros LJ, Tang G (2019) Acute myeloid leukemia with t(8;16)(p11.2;p13.3)\/KAT6A-CREBBP in adults. Ann Hematol 98(5):1149\u20131157. https:\/\/doi.org\/10.1007\/s00277-019-03637-7","journal-title":"Ann Hematol"},{"issue":"5","key":"3909_CR38","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/leu.2008.388","volume":"23","author":"T Haferlach","year":"2009","unstructured":"Haferlach T, Kohlmann A, Klein HU, Ruckert C, Dugas M, Williams PM, Kern W, Schnittger S, Bacher U, Loffler H, Haferlach C (2009) AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia 23(5):934\u2013943. https:\/\/doi.org\/10.1038\/leu.2008.388","journal-title":"Leukemia"},{"issue":"1","key":"3909_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1182\/blood-2006-01-023101","volume":"109","author":"S Bhatia","year":"2007","unstructured":"Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, Grier HE, Link MP, Meyers PA, Perlman EJ, Rausen AR, Robison LL, Vietti TJ, Miser JS (2007) Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children\u2019s Oncology Group. Blood 109(1):46\u201351. https:\/\/doi.org\/10.1182\/blood-2006-01-023101","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03909-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-020-03909-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-03909-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:56:51Z","timestamp":1611968211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-020-03909-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["3909"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-03909-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]},"assertion":[{"value":"29 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a retrospective study and all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}